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ABSTRACT
Background: The underlying cause of death is used to study country and global
mortality trends and proﬁles. The ﬁnal cause of death could also inform the ultimately
cause of death in individuals with underlying conditions. Whether there is a pattern
between the underlying and ﬁnal cause of death has not been explored using
national death registries. We studied what ﬁnal causes of death were most common
among selected underlying causes using national death registries in Peru, 2015.
Methods: Underlying and ﬁnal causes of death were classiﬁed according to their
ICD-10 codes. Underlying causes included chronic kidney disease (CKD),
chronic obstructive pulmonary disease (COPD), hypertension (HTN), diabetes, and
selected cancers (cervix, breast, stomach, prostate, and lung). Final causes were
categorized as: communicable, cardiovascular, and cancers. Descriptive statistics
were used.
Results: A total of 77,065 death registries were analyzed; cases had a mean age of 69.4
(SD: 19.3) years at death and were mostly men (53.9%). When the underlying cause
was HTN, the most frequent ﬁnal cause was cardiovascular diseases (82.3%). For all
the other underlying causes, the most frequent ﬁnal cause was communicable
diseases: COPD (86.4%), CKD (79.3%), cancer (76.5%), and diabetes (68.3%).
Conclusions: In four selected underlying causes of death there was a divergence with
respect to the ﬁnal cause, suggesting there was a shift from non-communicable
to communicable causes. Although efforts should be deployed to prevent underlying
non-communicable diseases, potential communicable complications should not
be neglected.
Subjects Epidemiology, Evidence Based Medicine, Global Health
Keywords Cause of death, Mortality, Cardiovascular diseases, Non-communicable diseases,
Communicable diseases, Peru
INTRODUCTION
Global reports use the underlying cause of death to inform death trends and proﬁles (GBD
2016 Causes of Death Collaborators, 2017). This approach is relevant from a public health
perspective because delaying or avoiding the underlying cause would prevent the chain of
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events leading to death. However, from a public health and clinical perspective,
understanding the ﬁnal cause of death is also relevant. For example, whether a patient with
type 2 diabetes is likely to ﬁnally perish of a coronary event or sepsis could guide what
information should be provided to these patients (i.e., patient empowerment) and to health
personnel looking after them. Information could thus target prevention of non-
communicable diseases, communicable disease, or both. From a clinical perspective,
understanding the patterns between underlying and ﬁnal cause of death could provide
clinicians with evidence on what to prevent during hospitalizations or emergency visits.
Finally, understanding the underlying-ﬁnal cause of death proﬁle could provide additional
insights into the epidemiological transition. Although most countries now face a large
(underlying) mortality burden of non-communicable diseases (GBD 2016 Causes of Death
Collaborators, 2017; GBD 2016 DALYs and HALE Collaborators, 2017; GBD 2016 Disease
and Injury Incidence and Prevalence Collaborators, 2017), hence allocating resources to
prevent them, understating what the ﬁnal causes of death are could help to prevent
complications, that is, ﬁnal causes of death. To the best of our knowledge, although
multiple countries and international groups have made relevant efforts to improve and
report underlying causes of death, little has been done to study the ﬁnal causes of death and
how these interact with the underlying ones. Consequently, we aimed to describe the ﬁnal
causes of death of selected underlying causes using national death registries in Peru, 2015.
METHODS
Data sources and subjects
Death registries were requested from the Peruvian Ministry of Health (Ministerio de Salud
del Perú, 2018a). These records compile death certiﬁcates from all health systems in Peru,
though underreporting could be expected from facilities outside the ministry system (e.g.,
private clinics). Available data included underlying and ﬁnal cause of death (ICD-10
codes), geographic location, sex, and age at death.
For this study people aged 18 years or above were included, because most of the diseases
of interest (e.g., type-2 diabetes mellitus) are uncommon in children. In addition, records in
which the ﬁnal cause was cardiac arrest (ICD-10: I48), chronic kidney disease (CKD)
(ICD-10: N18), type 2 diabetes mellitus (ICD-10: E10, E11, E13), chronic obstructive
pulmonary disease (COPD) (ICD-10: J41, J42, J44), hypertension (HTN) (ICD-10: I10),
and selected cancers (ICD-10: C16 (stomach), C61 (prostate), C34 (bronchus and lung),
C53 (cervix uteri), C50 (breast)), were excluded. Cardiac arrest cases in the ﬁnal cause of
death were excluded to improve the data quality, as it is not a clearly deﬁned diagnosis.
The other conditions, which were also the underlying causes of interest, were excluded to
improve data quality and avoid overlapping between underlying and ﬁnal cause of
death, that is, a registry with the same underlying and ﬁnal cause which could imply data
quality issues or an unintended error when ﬁlling in the certiﬁcate. The number of
observations excluded at each step of data cleaning is depicted in Fig. S1.
Characteristics of data sources
Although the analyzed death registries have a national coverage, there could have been
relevant under-reporting. In 2011 the coverage of the death registry was 53.8%; in other
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words, roughly half of all the expected deaths were registered (Ministerio de Salud del Perú,
2018b). Moreover, there was wide variation across regions, ranging from 21.9% to 80.7%
coverage (Ministerio de Salud del Perú, 2018b). Fortunately, though to the best of our
knowledge it has not been quantiﬁed and reported, these coverage estimates have
improved. At some extent, this argument has been supported by coverage reported by the
Global Burden of Disease team (GBD 2016 Causes of Death Collaborators, 2017).
This underreporting would have implications on the results, interpretation and impact of
this work. First, the ﬁndings should be understood in the context of the underreporting issue,
meaning these ﬁndings would not tell a complete picture but rather an introduction of
what could be happening. Nonetheless, the results could tell a story that needs further
veriﬁcation, fostering the improvement of available registries as it has been done with the
introduction of online registries in Pardo et al. (2015). Second, and with regards to this work
and the communicable diseases outcome, these estimates could be under-reported assuming
worse coverage in resource-limited settings, which would be where most communicable
(infectious) diseases occur. If this is the case, we could expect higher rates of communicable
disease deaths.
Variables
We studied two causes of death as reported on death certiﬁcates based on ICD-10 codes.
The underlying cause of death refers to that one which initiated the chain of
pathological events that led to death, while the ﬁnal cause of death is the disease or
event that produced death directly (Department of Health and Human Services, 2003).
We primarily focused on non-communicable underlying causes of death: CKD,
diabetes, COPD, HTN, and selected cancers (ICD-10 codes shown in the data sources and
subjects section above); we also generated one category for all others causes of death. We
focused on these non-communicable causes because they are leading causes of death (GBD
2016 Causes of Death Collaborators, 2017; Fitzmaurice et al., 2018; Perú Cancer Proﬁle–
PAHO, 2014). On the other hand, the ﬁnal causes of death were classiﬁed in three groups:
communicable, cardiovascular (CVDs) and neoplasms. Their ICD-10 codes were classiﬁed
according to the Global Burden of Disease Study criteria (GBD 2016 Causes of Death
Collaborators, 2017), though with the following modiﬁcations: communicable ﬁnal causes
also included unspeciﬁed pneumonia (ICD-10: J18.9), unspeciﬁed bronchopneumonia
(ICD-10: J18.0), and unspeciﬁed sepsis (ICD-10: A41.9); CVDs also included stroke not
speciﬁed as haemorrhage or infarction (ICD-10: I64.0), unspeciﬁed heart failure (ICD-10:
I50.9), and congestive heart failure (ICD-10: I50.0). For a full description of ICD-10 codes
included in the ﬁnal causes, refer to Table S1.
We did not strictly follow the Global Burden of Disease classiﬁcation because we would
have experienced a massive loss of information; in fact, the codes that were included
in addition to the Global Burden of Disease classiﬁcation accounted for the largest
proportion of reported deaths. We chose this approach based on our knowledge of the
local context. For example, sepsis coded as unspeciﬁed sepsis (ICD-10: A41.9) would have
been considered a “garbage code” by the Global Burden of Disease classiﬁcation, but
we included it in our communicable diseases category. We made this decision because we
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believe that these cases could have been undeﬁned because of lack of laboratory
resources to further characterize this condition. However, despite of this limitation,
a sepsis would most likely be a communicable cause of death hence we included it in such
group. For transparency sake, results according to the Global Burden of Disease
classiﬁcation are shown as Fig. S2.
Statistical analysis
Categorical variables are described as frequencies as well as proportions with 95%
conﬁdence intervals (95% CI), and comparisons between them were computed with
the Chi2 test. Numerical variables were described as mean and standard deviation.
A sensitivity analysis was conducted with the ﬁnal causes of death as per the Global Burden
of Disease Study criteria, which follow a more strict classiﬁcation. Analyses were
conducted with STATA 13.0 (StataCorp, College Station, TX, USA). Data was analyzed
without further re-distribution of ill-deﬁned ICD-10 codes.
Ethical considerations
De-identiﬁed data was used; hence privacy of individuals was protected. Because this work
was of low risk to human subjects and data were freely available, approval from an
Institutional Review Board was not sought.
RESULTS
General characteristics
There were 77,065 studied observations, with a mean age at death of 69.4 (SD: 19.3) years
ranging from 18 to 115; there were more men (53.9%). Of the selected underlying cause of
death, diabetes accounted for 1.1% (95% CI [1.0–1.2%]), CKD for 2.0% (95% CI [1.9–
2.1%]), COPD for 1.7% (95% CI [1.6–1.8%]), HTN for 2.4% (95% CI [2.3–2.5%]), and
cancers for 6.4% (95% CI [6.2–6.6%]). There was a sex difference (p < 0.001), with more
women deaths in the diabetes (1.2% vs 1.0%), COPD (1.8% vs 1.7%), HTN (2.5% vs 2.2%),
and cancer (7.3% vs 5.7%) groups (Table S2).
Final causes of death
Communicable diseases accounted for the largest share (60.0%; 95% CI [59.4–60.5%]),
followed by cardiovascular (29.8%; 95% CI [29.2–30.3%]) and cancers (10.3%;
95% CI [9.9–10.6%]). There was a sex difference (p < 0.001) with more women in the
communicable (60.4% vs 59.5%) and cancer (11.2% vs 9.4%) categories (Table S3).
Figure 1 shows that when HTN was the underlying cause of death, the largest ﬁnal cause
was CVDs (82.3%). The other underlying causes of death had a non-trivial share of
communicable diseases as ﬁnal cause of death, with COPD showing the largest (86.4%)
share, followed by CKD (79.3%), cancer (76.5%), and diabetes (69.3%, Table S4). Table 1
shows the top three ﬁnal causes of death in each underlying cause.
Sensitivity analysis
Figure S2 shows that in sensitivity analysis the pattern of ﬁnal cause of death changed: all
underlying causes had a large share of CVDs as ﬁnal cause of death. The proﬁle of
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underlying and communicable ﬁnal cause of death remained similar; where COPD had the
largest share (25.5%) of ﬁnal communicable diseases, followed by cancer (18.5%), CKD
(14.3%), and diabetes (8.0%, Table S4).
DISCUSSION
Main findings
The results showed a divergent proﬁle between the underlying and ﬁnal cause of death.
In four non-communicable underlying causes of death, namely CKD, COPD, diabetes, and
cancer, the ﬁnal cause of death was largely a communicable condition; however, when
HTN was the underlying cause, cardiovascular events were the predominant ﬁnal cause.
These results suggest that, even though Peru is undergoing epidemiological transition
with non-communicable diseases leading the mortality rankings (GBD 2016 Causes of
Death Collaborators, 2017; Huicho et al., 2009), communicable diseases still play a non-
trivial role in the ﬁnal cause of death. This calls for a synergism between health policies and
practice of non-communicable and communicable diseases. In addition, our ﬁndings
could also hide a biological fact: reduced immunity in patients with underlying non-
communicable diseases could ultimately lead to communicable illnesses. Improving
Figure 1 Final cause of death in selected underlying causes, 2015. This ﬁgure is to be read horizontally:
starting from all deaths (ﬁrst node or column), how many of these were due to the selected underlying
causes of death (second set of nodes or second column), and of these how many were attributed to the
studied ﬁnal causes of death (last set of nodes or last column). The width of the links between nodes is
relative to the proportion of deaths, that is, the wider the link the larger the proportion. Interpretation:
from all deaths that occurred in 2015, the largest proportion was due to other causes (wider link going
from all deaths to other causes); also, when hypertension was the underlying cause of death, the largest
ﬁnal cause fall in the cardiovascular category (wider link going from HTN to CVDs). CKD, chronic
kidney disease; COPD, chronic obstructive pulmonary disease; HTN, hypertension; CVD, cardiovascular
diseases. Refer to Table S5 for the exact estimates. Full-size DOI: 10.7717/peerj.5948/ﬁg-1
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nutrition among these patients, advising and providing them with information to avoid
communicable diseases may be relevant, and even to strengthen vaccination coverage (e.g.,
inﬂuenza) for these patients as is the case with the elderly.
Accounting for its limitations, this work adds to the literature evidence from the general
population, that is, not based on cohorts of speciﬁc diseases. This preliminary work based on
death registries builds the ﬁrst step to better characterize, hence understand, the complex
Table 1 Top three ﬁnal causes of death according to each underlying cause.
Diabetes (N = 363)
Communicable (N = 248) Cardiovascular (N = 112) Cancer (N = 3)
Unspeciﬁed sepsis (28.3%) Unspeciﬁed acute myocardial infarction (54.5%) Malignant neoplasm of gallbladder (33.3%)
Unspeciﬁed pneumonia (11.3%) Heart failure (7.1%) Malignant neoplasm of kidney,
except renal pelvis (33.3%)
Unspeciﬁed bronchopneumonia (3.2%) Unspeciﬁed heart failure (7.1%) Unspeciﬁed major salivary gland (33.3%)
Chronic kidney disease (N = 511)
Communicable (N = 405) Cardiovascular (N = 103) Cancer (N = 3)
Unspeciﬁed sepsis (84.0%) Unspeciﬁed acute myocardial infarction (39.8%) Multiple myeloma (33.3%)
Unspeciﬁed pneumonia (11.1%) Heart failure (16.5%) Oesophagus (33.3%)
Unspeciﬁed bronchopneumonia (2.2%) Unspeciﬁed heart failure (14.6%) Unspeciﬁed myelodysplastic
syndrome (33.3%)
Chronic obstructive pulmonary disease (N = 382)
Communicable (N = 330) Cardiovascular (N = 52) Cancer (N = 0)
Unspeciﬁed sepsis (54.6%) Unspeciﬁed acute myocardial infarction (48.1%)
Unspeciﬁed pneumonia (32.4%) Unspeciﬁed heart failure (17.3%)
Unspeciﬁed bronchopneumonia (9.4%) Heart failure (9.6%)
Hypertension (N = 997)
Communicable (N = 175) Cardiovascular (N = 820) Cancer (N = 2)
Unspeciﬁed sepsis (72.6%) Unspeciﬁed acute myocardial infarction (51.8%) Unspeciﬁed colon (50.0%)
Unspeciﬁed pneumonia (17.1%) Stroke, not speciﬁed as hemorrhage
or infarction (19.8%)
Unspeciﬁed myelodysplastic
syndrome (50.0%)
Unspeciﬁed bronchopneumonia (6.3%) Heart failure (5.4%)
Cancer (N = 1,189)
Communicable (N = 910) Cardiovascular (N = 147) Cancer (N = 132)
Unspeciﬁed sepsis (71.8%) Unspeciﬁed acute myocardial infarction (49.7%) Carcinoma in situ, stomach (20.5%)
Unspeciﬁed pneumonia (15.1%) Unspeciﬁed heart failure (20.4%) Carcinoma in situ, prostate (14.4%)
Unspeciﬁed bronchopneumonia (7.4%) Heart failure (6.8%) Carcinoma in situ, bronchus,
and lung (6.8%)
Note:
The Ns mean that, within each underlying cause of death, N people ﬁnally died of a communicable, cardiovascular or cancer cause. For example, refer to diabetes as
underlying cause of death: among those whose underlying cause of death was diabetes, 248 ﬁnally died of a communicable cause, 112 of a cardiovascular cause, and three
of a cancer; within diabetes as the underlying cause of death, and among those 248 who ﬁnally died of a communicable disease, 28.3% (of 248) died of unspeciﬁed
sepsis, 11.3% of unspeciﬁed pneumonia, and 3.2% of unspeciﬁed bronchopneumonia (these were the top three ﬁnal communicable causes of death where diabetes was the
underlying cause). The same interpretation follows for the other underlying and ﬁnal causes of death.
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interactions between non-communicable and communicable causes of death, that is,
multi-morbidity (multi-mortality). The results do not suggest that Peru is at a different stage
of the epidemiological transition. However, the results invite us to think beyond these
global metrics and understand that, even though Peru is at a stage where non-communicable
diseases are more prevalent, communicable disease still accounts for a non-negligible
proportion of ﬁnal causes of death. We therefore recommend focusing on strengthening care
for non-communicable diseases, while also keeping efforts up against communicable illnesses.
Comparison with available evidence and interpretation of results
A population-based cohort in Mexico showed that the rate ratio comparing diabetes vs no
diabetes was larger when the outcome was infections (respiratory or gastrointestinal) than
when it was cardiovascular mortality (Alegre-Diaz et al., 2016). This observation agrees
with our overall results because the ﬁnal cause of death when the underlying cause was
diabetes was largely communicable illnesses. This similarity probably reﬂects poor
awareness, treatment and control in diabetic patients (Azañedo et al., 2017;
Herrington et al., 2018; Huayanay-Espinoza et al., 2016; Lerner et al., 2013).
In Canada, a registry-based study found that in people with CKD the leading cause of
death was cardiovascular events; in addition, they also reported that with worse kidney
function, the risk of dying of an infectious cause increased (Thompson et al., 2015).
This observation had also been retrieved in the USA and Canada studying pneumonia
fatalities (James et al., 2009;Wang et al., 2011). To the best of our knowledge this evidence
is lacking in Peru where CKD mortality has only been studied in hospitals and patients in
renal replacement therapy (Herrera-Añazco, Pacheco-Mendoza & Taype-Rondan, 2016).
A hospital-based study in northern Peru reported that the ﬁrst cause of death in CKD
patients was CVD followed by infections (Concepción-Zavaleta et al., 2015). It seems
that our primary results disagree with the available evidence. This could be explained by
ascertainment of the outcome variable. Studies in high-income countries and those
in restricted hospital-based populations could have followed a stronger methodology to
assess the outcome. This hypothesis is supported by our sensitivity analysis in which
cardiovascular events seemed to be the largest ﬁnal cause of death when CKD was the
underlying cause. This discrepancy and potential explanation call for cautious
interpretation of these ﬁndings and for strengthening the mortality reporting systems in
Peru (Zolezzi, 2017).
A Spanish COPD patient-based cohort reported different causes of death according
to COPD proﬁle; of note, in none of the studied proﬁles did a communicable disease
prevail over cardiovascular causes of death (Golpe et al., 2018). This disagrees with our
primary results, which could be explained by outcome ascertainment methods as
previously discussed. However, this could also hide other clinical patterns such as therapy.
For example, COPD patients on inhaled corticosteroids may have worse outcomes,
including death, in the presence of community-acquired pneumonia (Liu, Han & Liu,
2018). To the best of our knowledge there is no evidence on mortality or treatment
patterns in COPD patients in Peru. Although largely speculative, if inhaled corticosteroids
were the leading treatment, this could explain our results.
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In the USA a registry-based study showed that breast and prostate cancer patients
had a higher frequency of a non-cancer death (Zaorsky et al., 2017). In addition, the top
non-cancer cause of death appeared to be cardiovascular conditions, the second cause was
infectious illnesses (Zaorsky et al., 2017); moreover, they also found that in people younger
than 45 years, infections accounted for a relevant share of deaths, whereas in older
people, heart diseases surpassed infections (Zaorsky et al., 2017). Our primary results
showed that communicable conditions were the leading cause of death, whereas our
sensitivity analysis agreed with Zaorsky et al. (2017). The discrepancy could be due to
different methods of assessing the outcome or different cardiovascular proﬁles between
populations. With regards to the age ﬁnding, post-hoc analysis (data not shown in main
results) yielded similar observations: for our primary outcome when the underlying cause
of death was cancer and age was restricted to younger than 45 years, 80.5% eventually
died of a communicable cause, whilst this percentage for people 45 years and above
was 76.2%; on the other hand, when this post-hoc analysis was conducted with the
outcome for sensitivity analysis, these percentages were 29.4% and 17.8%, respectively.
These results also suggests that when there is an underlying cancer, infectious causes of
death may be more frequent in younger than older people. This ﬁnding deserves
further examination with larger sample sizes in both age groups to understand the proﬁles
and risk factors of these sub-populations.
Hypertension is known to be a key risk factor for cardiovascular events, and our results
conﬁrm this knowledge. In addition, our results point that in some deaths with underlying
HTN the ﬁnal cause was a communicable disease. This could signal a complication
of cardiovascular events, such as post-stroke infections (Castaneda-Guarderas et al., 2011;
Westendorp et al., 2011).
Public health and clinical relevance
Our results show a divergence between the underlying and ﬁnal cause of death, that is,
non-communicable causes and eventually dying of a communicable illness. From a public
health perspective these results could signal that CKD, COPD, diabetes, and cancer patients
should be aware of how to control their underlying condition, but also of the potential
communicable complications so that they can identify them early. In addition, the results
may call for providing health personnel and facilities with resources to successfully address
both communicable and non-communicable diseases in addition to these underlying
conditions.
Strengths and limitations
The strengths of this work include using a large national death registry based on death
certiﬁcates, and the analysis of both underlying and ﬁnal causes of death. Nevertheless, the
limitations included the lack of information on other health and socio-demographic
variables such as adherence to treatment, disease control or educational attainment,
which could modify and explain the patterns herein explored (Herrington et al., 2018).
However, our results still provide evidence of a divergence between the underlying and
ﬁnal cause of death. Future studies should explore the determinants at the individual
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and public health level of this divergence. Second, information was not available about the
events between the underlying and ﬁnal cause of death, should there have been any.
For example, for deaths that occurred in a hospital, the ﬁnal cause could have been a
communicable disease even though the hospitalization was due to a non-communicable
illness (e.g., COPD patient hospitalized due to a coronary syndrome with acquired
pneumonia as the ﬁnal cause of death). Nonetheless, our results raise awareness that some
non-communicable diseases may have a non-negligible chance of dying of a
communicable disease, signaling that we should not lose sight of these diagnoses should
not be lost even though other (non-communicable) conditions seemed more important
at the time. This could be relevant in resource-limited settings where lack of human
and logistical resources make it difﬁcult to consider all potential possibilities.
CONCLUSIONS
In a middle-income country undergoing epidemiological transition, there seems to be a
divergence between the overall proﬁle of the underlying and ﬁnal cause of death. In four
major non-communicable diseases—CKD, COPD, diabetes, and cancers, the ﬁnal
cause of death was largely a communicable illness; whereas in HTN it was a cardiovascular
event. Although efforts should be deployed to prevent underlying non-communicable
diseases, potential communicable complications should not be neglected.
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